SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001048477-24-000092
Filing Date
2024-05-23
Accepted
2024-05-23 17:06:57
Documents
3
Period of Report
2024-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1716498400.html 4  
1 FORM 4 wk-form4_1716498400.xml 4 3167
2 EX-24 section16filingspowerofa.htm EX-24 3906
3 section16filingspowerofa001.jpg GRAPHIC 220783
  Complete submission text file 0001048477-24-000092.txt   312673
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Business Address
ANDERSON ELIZABETH M (Reporting) CIK: 0001758247 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26727 | Film No.: 24979527